AI Governance

AWS AI Opt-Out Isn't an Audit Trail: What Compliance Teams Need to Know

AWS lets customers opt out of AI data use via AWS Organizations, but the Service Terms don't describe a timestamped record of when that setting was configured — a gap worth checking as AWS's Bedrock-powered service list keeps growing.

💡

TL;DR:
AWS lets you opt out of AI data use through AWS Organizations, but the setting alone won't satisfy an auditor asking when it was configured. The Bedrock-powered service list has more than doubled since August 2025 — check your documentation before that gap gets found for you.

What you need to know

The change: AWS's AI-related service and feature list has more than doubled over the past year; Section 1.23 places AI/ML compliance responsibility — including for third-party models AWS hosts but didn't build — on the customer.
Who is affected: Any organization using AWS services or features with generative AI functionality, including Amazon Q, AWS Transform, AWS HealthScribe, AWS Continuum, and 25 other services or features named in the current terms.
Why it matters: Configuring an opt-out policy changes the customer's instruction to AWS about covered use of customer content for service improvement. It's a different thing than being able to show, later, exactly when that instruction was given and what it covered.
What to do first: Check whether your AI governance file can answer "when was this configured, and against which version of AWS's service list?" — not just "is it configured now?"

The signal is public. The implications are not.

Members receive deeper analysis and early warnings inside the PolicyEdge AI Intelligence Terminal.

Upgrade to Founding Member

Medicaid work requirements move along parallel pathways through three review points on a dark policy-intelligence grid.

Medicaid Work Requirements: What the Court Ruling Changes—and What It Doesn’t

A federal court declined to block three CMS provisions governing Medicaid work requirements. The ruling leaves the implementation timeline in place for now without resolving the legal merits.

EU AI Act Article 50 shown as linked data paths separating system marking from public disclosure.

EU AI Act Article 50: What the Transparency Rules Require

EU AI Act Article 50 is now applicable, but it does not require one universal AI label. Learn how duties differ by organizational role, system, content type and exception.

June 2026 JOLTS report visual showing subtle labor-market signals without a clear hiring trend.

June 2026 JOLTS Report: Why the Data Do Not Show a Hiring Rebound

BLS reported job openings as little changed at 7.4 million and hires as unchanged at 5.3 million in June. The data did not establish a hiring rebound—and national estimates alone cannot determine whether a company’s critical roles are becoming easier to fill.

Trump generic-drug tariffs shown as cyan supply-chain paths crossing an amber threshold and branching into uncertain routes.

Trump Generic-Drug Tariffs: What Businesses Can—and Cannot—Plan For

Trump’s announced generic-drug tariffs could reshape supply chains beginning in 2028. Here is what manufacturers, healthcare purchasers and boards can assess now—and which unanswered policy questions prevent reliable forecasts.